ChromaDex Newsroom

Roth MKM Maintains ChromaDex(CDXC.US) With Buy Rating, Raises Target Price to $8

Moomoo NewsNov 6 08:37 ET

ChromaDex Analyst Ratings

BenzingaNov 4 06:52 ET

H.C. Wainwright Maintains ChromaDex(CDXC.US) With Buy Rating, Raises Target Price to $8

Moomoo NewsNov 4 06:31 ET

ChromaDex's Robust Q3 Performance and Strategic Initiatives Drive 'Buy' Rating With Raised Price Target

TipRanksNov 4 06:29 ET

Roth MKM Maintains ChromaDex(CDXC.US) With Buy Rating, Maintains Target Price $6

Moomoo NewsOct 22 09:31 ET

Analysts Are Bullish on Top Healthcare Stocks: Chromadex (CDXC), Anika Therapeutics (ANIK)

TipRanksOct 22 09:27 ET

ChromaDex Analyst Ratings

BenzingaAug 9 17:31 ET

HC Wainwright & Co. Reiterates Buy on ChromaDex, Maintains $6 Price Target

BenzingaAug 9 17:30 ET

Buy Rating Affirmed on Chromadex's Turnaround and Growth Prospects

TipRanksAug 9 08:14 ET

Roth MKM Remains a Buy on Chromadex (CDXC)

TipRanksAug 8 09:52 ET

Roth MKM Maintains ChromaDex(CDXC.US) With Buy Rating, Maintains Target Price $6

Moomoo NewsJul 29 08:31 ET

Analysts' Top Healthcare Picks: Chromadex (CDXC), Tarsus Pharmaceuticals (TARS)

TipRanksJul 29 08:05 ET

ChromaDex Analyst Ratings

BenzingaJul 15 06:40 ET

Buy Rating Affirmed for Chromadex on Niagen+ Launch and Market Potential

TipRanksJul 15 06:18 ET

ChromaDex Analyst Ratings

BenzingaJun 12 11:47 ET

ChromaDex Analyst Ratings

BenzingaMay 9 07:27 ET

ChromaDex Analyst Ratings

BenzingaApr 9 10:00 ET

ChromaDex Analyst Ratings

BenzingaMar 11 07:24 ET

Chromadex's Strong Financial Performance and Strategic Growth Initiatives Drive Buy Rating: An Analysis of Jeffrey Cohen's Recommendations

TipRanksNov 9, 2023 12:19 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Fate Therapeutics (FATE), Chromadex (CDXC) and Glaukos (GKOS)

TipRanksNov 9, 2023 07:22 ET